Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD19 antibody

This Monoclonal antibody specifically detects CD19 in WB, IHC and ELISA. It exhibits reactivity toward Human. It has been mentioned in 2+ publications
Catalog No. ABIN965770
-15% Promotion 2026
$444.12
$522.50
save $78.38 (-15 %)
Plus shipping costs $50.00
0.1 mg
Shipping to: United States
Delivery in 4 to 6 Business Days

Quick Overview for CD19 antibody (ABIN965770)

Target

See all CD19 Antibodies
CD19 (CD19 Molecule (CD19))

Reactivity

  • 425
  • 185
  • 53
  • 33
  • 19
  • 13
  • 6
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Human

Host

Please inquire

Clonality

  • 402
  • 114
  • 6
Monoclonal

Conjugate

  • 190
  • 30
  • 29
  • 27
  • 25
  • 15
  • 8
  • 7
  • 7
  • 6
  • 6
  • 6
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
This CD19 antibody is un-conjugated

Application

  • 341
  • 147
  • 84
  • 76
  • 75
  • 62
  • 40
  • 24
  • 19
  • 15
  • 15
  • 14
  • 10
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA
  • Specificity

    Ni-NTA purified recombinant human CD19 expressed in E. Coli strain M15.

    Purification

    Antibodies are purified by protein A affinity chromatography

    Isotype

    IgG2a
  • Application Notes

    Western Blot: Dilution 1: 2000- 5,000
    IHC(P): Dilution 1: 100- 1: 400
    IHC(F): Dilution 1: 200- 1: 400
    ELISA: Propose dilution 1: 10,000.
    Determining optimal working dilutions by titration test.
    Determining optimal working dilutions by titration test.

    Restrictions

    For Research Use only
  • Storage

    -20 °C
  • de Rie, Zeijlemaker, von dem Borne: "Inhibition, by vinca alkaloids and colchicine, of antigenic modulation induced by anti-CD19 monoclonal antibodies." in: Leukemia research, Vol. 12, Issue 2, pp. 135-41, (1988) (PubMed).

    De Rie, Zeijlemaker, Von dem Borne, Out: "Evaluation of a method of production and purification of monoclonal antibodies for clinical applications." in: Journal of immunological methods, Vol. 102, Issue 2, pp. 187-93, (1987) (PubMed).

  • Target

    CD19 (CD19 Molecule (CD19))

    Alternative Name

    CD19

    Background

    The CD19 antigen (95kDa) is expressed from the earliest stage of B progenitor development, on all peripheral B cells including germinal centre B cells, and all B cell lines and B cell leukaemia tested. T cell and monocytic cell lines are negative and the antigen is lost on B cell maturation to plasma cells. The antigen is a type I integral membrane glycoprotein whose in vitro inhibition will influence B cell activation and proliferation.

    Gene ID

    930

    Pathways

    Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway
You are here:
Chat with us!